Published Application/Species/Sample/Dilution | Reference |
---|
- flow cytometry; human; loading ...
| Zeltner N, Fattahi F, Dubois N, Saurat N, Lafaille F, Shang L, et al. Capturing the biology of disease severity in a PSC-based model of familial dysautonomia. Nat Med. 2016;22:1421-1427 pubmed publisher
|
- flow cytometry; human; fig 2
| Flavahan W, Drier Y, Liau B, Gillespie S, Venteicher A, Stemmer Rachamimov A, et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature. 2016;529:110-4 pubmed publisher
|
| Fuentes T, Appleby N, Tsay E, Martinez J, Bailey L, Hasaniya N, et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS ONE. 2013;8:e77464 pubmed publisher
|
| Tamaoki N, Siebert S, Maeda T, Ha N, Good M, Huang Y, et al. Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells. Cell Rep Methods. 2023;3:100460 pubmed publisher
|
| Li W, Berlinicke C, Huang Y, Giera S, McGrath A, Fang W, et al. High-throughput screening for myelination promoting compounds using human stem cell-derived oligodendrocyte progenitor cells. iScience. 2023;26:106156 pubmed publisher
|
| Liu X, Yuan M, Xiang Q, Li Z, Xu F, Chen W, et al. Single-cell RNA sequencing of subcutaneous adipose tissues identifies therapeutic targets for cancer-associated lymphedema. Cell Discov. 2022;8:58 pubmed publisher
|
| De Bacco F, Orzan F, Erriquez J, Casanova E, Barault L, Albano R, et al. ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma. Cell Rep. 2021;36:109455 pubmed publisher
|
| Yamanaka S, Matsui K, Fujimoto T, Takamura T, Saito Y, Matsumoto N, et al. In vivo regeneration of neo-nephrons in rodents by renal progenitor cell transplantation. STAR Protoc. 2021;2:100314 pubmed publisher
|
| Fujimoto T, Yamanaka S, Tajiri S, Takamura T, Saito Y, Matsumoto N, et al. Generation of Human Renal Vesicles in Mouse Organ Niche Using Nephron Progenitor Cell Replacement System. Cell Rep. 2020;32:108130 pubmed publisher
|
| Liu J, Li P, Wang L, Li M, Ge Z, Noordam L, et al. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance. Cell Mol Gastroenterol Hepatol. 2021;11:407-431 pubmed publisher
|
| Leelatian N, Sinnaeve J, Mistry A, Barone S, Brockman A, Diggins K, et al. Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells. elife. 2020;9: pubmed publisher
|
| Morales Pantoja I, Smith M, Rajbhandari L, Cheng L, Gao Y, Mahairaki V, et al. iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu. PLoS ONE. 2020;15:e0233980 pubmed publisher
|
| Dmitrieva R, Lelyavina T, Komarova M, Galenko V, Ivanova O, Tikanova P, et al. Skeletal Muscle Resident Progenitor Cells Coexpress Mesenchymal and Myogenic Markers and Are Not Affected by Chronic Heart Failure-Induced Dysregulations. Stem Cells Int. 2019;2019:5690345 pubmed publisher
|
| Xu S, Yang Z, Jin P, Yang X, Li X, Wei X, et al. Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer. Mol Cancer Ther. 2018;17:1291-1302 pubmed publisher
|
| Koide M, Hagiwara Y, Tsuchiya M, Kanzaki M, Hatakeyama H, Tanaka Y, et al. Retained Myogenic Potency of Human Satellite Cells from Torn Rotator Cuff Muscles Despite Fatty Infiltration. Tohoku J Exp Med. 2018;244:15-24 pubmed publisher
|
| Saison Ridinger M, DelGiorno K, Zhang T, Kraus A, French R, Jaquish D, et al. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy. PLoS ONE. 2017;12:e0189051 pubmed publisher
|
| Baio J, Walden R, Fuentes T, Lee C, Hasaniya N, Bailey L, et al. A Hyper-Crosslinked Carbohydrate Polymer Scaffold Facilitates Lineage Commitment and Maintains a Reserve Pool of Proliferating Cardiovascular Progenitors. Transplant Direct. 2017;3:e153 pubmed publisher
|
| Liau B, Sievers C, Donohue L, Gillespie S, Flavahan W, Miller T, et al. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. Cell Stem Cell. 2017;20:233-246.e7 pubmed publisher
|
| Guarnerio J, Riccardi L, Taulli R, Maeda T, Wang G, Hobbs R, et al. A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells. Cancer Discov. 2015;5:396-409 pubmed publisher
|
| Lottaz C, Beier D, Meyer K, Kumar P, Hermann A, Schwarz J, et al. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res. 2010;70:2030-40 pubmed publisher
|